Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
Sitbon, Olivier; Jaïs, Xavier; Savale, Laurent; Cottin, Vincent; Bergot, Emmanuel; Macari, Elise Artaud; Bouvaist, Hélène; Dauphin, Claire; Picard, François; Bulifon, Sophie; Montani, David; Humbert, Marc; Simonneau, Gérald.
Eur Respir J
; 43(6): 1691-7, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24627535
Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension.
Does sildenafil enhance the effect of tamsulosin in relieving acute urinary retention?
Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan.
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.
Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension.
Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension.
Behandling av idiopatisk pulmonal arteriell hypertensjon.
Survival after the initiation of combination therapy in patients with pulmonary arterial hypertension: an Australian collaborative report.
Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy.